| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |